Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ILIKA PLC AGM Information 2018

Oct 4, 2018

7701_agm-r_2018-10-04_c1697e31-64ef-45a8-bff3-54e61fb848eb.html

AGM Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8910C

Ilika plc

04 October 2018

Ilika Plc

("Ilika" or the "Company")

AGM Statement

Ilika plc (AIM: IKA), the advanced solid-state battery technology and materials innovation company, will hold its Annual General Meeting at 2pm today at the offices of Eversheds LLP, One Wood Street, London, EC2V 7WS. Ahead of the formal proceedings, Graeme Purdy, Chief Executive of Ilika, will provide the following update to shareholders:

"Ilika's thin-film Stereax® development roadmap has continued in-line with expectations, with shipments of evaluation samples of miniature mm-scale cells (codenamed 'Project Golden Hind') made to customers in the USA and Asia. These cells are destined for integration into prototype implantable medical devices, which are going through product development approval programmes. The cells have been produced on Ilika's pilot line in Southampton, UK, which recently delivered its highest monthly cathode-production productivity to date.

"The mm-scale Stereax® cells have now been released to customers under commercial arrangements covering partner agreements for cell evaluation in advance of Ilika's next planned product launch in early 2019.

"Further to our announcement on 13 June 2018, confirming Ilika has received offers of grant funding from the Faraday Battery Challenge amounting to £4.1m in aggregate, Ilika has been working with its project partners to finalise the collaboration agreements. The PowerDrive Line project agreement has been signed by all parties and the project is expected to commence in October, pending final approval by Innovate UK. This is a 30-month collaborative project that will develop a lithium based solid-state Stereax® battery (codenamed 'Project Goliath') for plug in hybrid and electric vehicles, establish a pre-pilot line for solid-state battery cell technology and develop processes for a solid-state materials supply chain. The innovative solid-state technology will enable safer, more energy and power dense cells that will facilitate ultra-fast charging (enabling PHEV or BEV drivers to charge their cars in under 25 minutes).

"In order to house the pre-pilot line for Goliath, Ilika is expanding its facilities in Southampton, UK by a further 900 m2. Outfitting plans are currently being finalised, with construction work expected to commence later this calendar year."

Company Presentation

After the formal business of the AGM has come to an end, Graeme Purdy will provide a short presentation to investors with an overview of progress and strategy. No new material will be disclosed in the presentation and it will be made available on the website shortly after.

For more information contact:

Ilika plc
Tel: 023 8011 1400

www.ilika.com
Graeme Purdy, Chief Executive
Steve Boydell, Finance Director
Liberum Capital Limited Tel: 020 3100 2000
Andrew Godber, Cameron Duncan,

Trystan Cullen, William Hall
Walbrook PR Ltd Tel: 020 7933 8780 / [email protected]
Paul Cornelius Mob: 07866 384 707
Lianne Cawthorne Mob: 07584 391 303

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

AGMFKNDPQBDDFKK